Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.17 USD
Change Today 0.00 / 0.00%
Volume 6.8K
VASO On Other Exchanges
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

vasomedical inc (VASO) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/9/14 - $0.32
52 Week Low
12/15/14 - $0.14
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VASOMEDICAL INC (VASO)

Related News

No related news articles were found.

vasomedical inc (VASO) Related Businessweek News

No Related Businessweek News Found

vasomedical inc (VASO) Details

Vasomedical, Inc. designs, manufactures, markets, and supports enhanced external counterpulsation (EECP) therapy systems, ambulatory monitoring systems, and other medical equipment to physician and hospitals in the United States and internationally. The company operates through three segments, Sales Representation, Equipment, and Information Technology (IT). Its EECP technology is a non-invasive and outpatient therapy for the treatment of cardiovascular diseases, as well as angina, cardiogenic shock, acute myocardial infarction, and congestive heart failure. The company also develops wireless multi-parameter patient monitoring systems; and distributes GE Healthcare’s diagnostic imaging products, as well as offers in-service and training support for the EECP systems. In addition, it is involved in the healthcare IT business. Vasomedical, Inc. was founded in 1987 and is headquartered in Westbury, New York.

218 Employees
Last Reported Date: 03/30/15
Founded in 1987

vasomedical inc (VASO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $275.0K
Chief Financial Officer and Secretary
Total Annual Compensation: $185.0K
Senior Vice President, Director and Chief Exe...
Total Annual Compensation: $600.0K
Vice President of Finance and Controller
Total Annual Compensation: $160.0K
Compensation as of Fiscal Year 2014.

vasomedical inc (VASO) Key Developments

Vasomedical Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for 2015

Vasomedical Inc. reported earnings results for the fourth quarter and full year ended December 31, 2014. For the three months ended December 31, 2014, revenue increased 23% to $12.4 million from $10.1 million for the same period of 2013. This is attributable to a 30% increase in commission revenue from Sales Representation segment resulting from an increase in deliveries of GEHC equipment in the quarter and higher commission rates for the equipment delivered, offset by a decrease in Equipment segment revenues. Net income for the three months ended December 31, 2014 was $2.5 million, a 390% improvement compared with a net income of $0.5 million for the three months ended December 31, 2013. Income before taxes was $2,545,000 against $481,000 a year ago. Operating income was $2,506,000 against $414,000 a year ago. For the year ended December 31, 2014, revenue increased $2.1 million, or 6%, to $35.0 million, compared with $32.9 million for the year 2013. The increase was due primarily to higher installations of underlying equipment by GEHC in 2014 as well as higher commission rates for the equipment installed in 2014. For the year ended December 31, 2014, the company had net income of $1.1 million, or $0.01 per common share, compared with a net loss of $1.1 million, or $0.01 per common share, for the year ended December 31, 2013. Net cash increased by $1.1 million to $9.1 million at December 31, 2014, compared with net cash of $8.0 million at December 31, 2013. Income before taxes was $1,255,000 against loss before taxes of $1,203,000 a year ago. Operating income was $1,063,000 against operating loss of $1,290,000 a year ago. For 2015, the company expected continued profitability for the year. The company expects significant growth in 2015 in this recently initiated healthcare IT business segment and in the wireless patient monitoring product and related intellectual properties acquired in August 2014.

Vasomedical Inc. to Report Q4, 2014 Results on Mar 30, 2015

Vasomedical Inc. announced that they will report Q4, 2014 results on Mar 30, 2015

Vasomedical Inc., Q4 2014 Earnings Call, Mar 30, 2015

Vasomedical Inc., Q4 2014 Earnings Call, Mar 30, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VASO:US $0.17 USD 0.00

VASO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $35.05 USD +0.09
Koninklijke Philips NV €25.22 EUR +0.01
Siemens AG €98.25 EUR +0.086
Toshiba Corp ¥409.90 JPY +11.90
View Industry Companies

Industry Analysis


Industry Average

Valuation VASO Industry Range
Price/Earnings 13.4x
Price/Sales 0.7x
Price/Book 3.4x
Price/Cash Flow 14.3x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VASOMEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at